HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A Alietti Selected Research

OPP-EBV-CAD regimen

12/2000OPP-EBV-CAD regimen as salvage treatment in advanced refractory or resistant multiple myeloma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


A Alietti Research Topics

Disease

3Multiple Myeloma
01/2009 - 12/2000
2Hodgkin Disease (Hodgkin's Disease)
12/2000 - 04/2000
1Neoplasms (Cancer)
09/2009
1Histiocytosis
07/2001
1Myelodysplastic Syndromes (Myelodysplastic Syndrome)
07/2001
1Cytopenia
12/2000
1Plasma Cell Leukemia
12/2000
1Pain (Aches)
12/2000
1Proteinuria
12/2000

Drug/Important Bio-Agent (IBA)

1Thalidomide (Thalomid)FDA Link
07/2001
1CalciumIBA
12/2000
1Pharmaceutical PreparationsIBA
12/2000
1CytokinesIBA
04/2000

Therapy/Procedure

1Radiotherapy
09/2009
1Autologous Transplantation
01/2009
1Salvage Therapy
12/2000
1Therapeutics
12/2000
1OPP-EBV-CAD regimen
12/2000